Bloomberg Talks: Harvey Schwartz (Podcast)

Carlyle CEO Harvey Schwartz said he does not expect the Federal Reserve to raise interest rates repeatedly. Separately, Carlyle partnered with the MIT Generative AI Impact Consortium on a two-year research program to assess large-language-model applications in portfolio management and investment decision-making. The remarks are modestly supportive for private-market risk appetite but are primarily interview commentary rather than a material market catalyst.

Analysis

This is low-information commentary rather than a change in Carlyle’s earnings power, and the near-term signal for CG is limited. The relevant market mechanism is valuation: a stable-to-easier policy path lowers financing costs, improves exit-market activity and can support private-equity realization multiples, but those benefits require actual M&A, IPO and distribution data rather than executive expectations. CG’s shares should therefore remain more sensitive over the next 1-3 months to fundraising flows, fee-related earnings guidance and deployment pace than to this interview.

The AI initiative has little standalone valuation relevance absent evidence of proprietary data advantages, investment-process adoption, or measurable productivity gains. Large alternative managers already have access to similar models; any competitive edge will accrue primarily to firms that can turn AI into faster underwriting, lower operating costs at portfolio companies, or differentiated sourcing. The more investable second-order beneficiary is likely AI infrastructure and enterprise software, not a two-year research partnership at the asset-manager level.

Contrarianly, markets may be underpricing the asymmetry in private-credit and leveraged-buyout portfolios if rates stay restrictive for longer than executive consensus implies. Lower base rates can revive transactions, but may also compress direct-lending asset yields faster than funding costs and expose marks on floating-rate borrowers whose interest coverage has already weakened. Falsify a cautious CG view if quarterly distributable earnings and fee-related earnings accelerate alongside realizations and net inflows, rather than merely higher reported AUM valuations.

Key Decisions for Investors

• No incremental directional CG position solely on this interview; treat it as a watch item until the next earnings release provides fee-related earnings, fundraising, realizations and deployment data.
• For a 3-6 month easing-cycle expression, prefer a diversified alternatives basket long KKR and APO versus short CG only if CG’s next-quarter realizations or fundraising lag peers; the thesis is that scale and insurance/perpetual-capital platforms convert reopening capital markets into earnings faster. Exit if CG closes the growth gap in fee-related earnings.
• Monitor CG’s direct-lending and corporate-credit disclosures over the next two quarters: rising non-accruals, larger fair-value markdowns or weaker interest coverage would outweigh any multiple support from lower rates and justify a tactical underweight.
• Do not assign material upside to the AI program without disclosed operating metrics. Reassess only if management quantifies underwriting-cycle reduction, portfolio-company EBITDA improvement, or incremental investment performance attributable to deployed tools.